Rajkhowa, B.; Mehan, S.; Sethi, P.; Prajapati, A.; Suri, M.; Kumar, S.; Bhalla, S.; Narula, A.S.; Alshammari, A.; Alharbi, M.;
et al. RETRACTED: Rajkhowa et al. Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder. Pharmaceuticals 2022, 15, 959. Pharmaceuticals 2025, 18, 1763.
https://doi.org/10.3390/ph18111763
AMA Style
Rajkhowa B, Mehan S, Sethi P, Prajapati A, Suri M, Kumar S, Bhalla S, Narula AS, Alshammari A, Alharbi M,
et al. RETRACTED: Rajkhowa et al. Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder. Pharmaceuticals 2022, 15, 959. Pharmaceuticals. 2025; 18(11):1763.
https://doi.org/10.3390/ph18111763
Chicago/Turabian Style
Rajkhowa, Bidisha, Sidharth Mehan, Pranshul Sethi, Aradhana Prajapati, Manisha Suri, Sumit Kumar, Sonalika Bhalla, Acharan S. Narula, Abdulrahman Alshammari, Metab Alharbi,
and et al. 2025. "RETRACTED: Rajkhowa et al. Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder. Pharmaceuticals 2022, 15, 959" Pharmaceuticals 18, no. 11: 1763.
https://doi.org/10.3390/ph18111763
APA Style
Rajkhowa, B., Mehan, S., Sethi, P., Prajapati, A., Suri, M., Kumar, S., Bhalla, S., Narula, A. S., Alshammari, A., Alharbi, M., Alkahtani, N., Alghamdi, S., & Kalfin, R.
(2025). RETRACTED: Rajkhowa et al. Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder. Pharmaceuticals 2022, 15, 959. Pharmaceuticals, 18(11), 1763.
https://doi.org/10.3390/ph18111763
